Chenghua Luo

1.1k total citations
59 papers, 749 citations indexed

About

Chenghua Luo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Chenghua Luo has authored 59 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 17 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Chenghua Luo's work include Sarcoma Diagnosis and Treatment (17 papers), Cardiac tumors and thrombi (13 papers) and Vascular Tumors and Angiosarcomas (6 papers). Chenghua Luo is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Cardiac tumors and thrombi (13 papers) and Vascular Tumors and Angiosarcomas (6 papers). Chenghua Luo collaborates with scholars based in China, United States and Australia. Chenghua Luo's co-authors include Duane A. Compton, Jia Fu, Xun Ye, Jianfeng Liang, Xiaolin Chen, Yuanli Zhao, Naikang Zhou, Yaping Chen, Wen Wang and Huirong Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Scientific Reports.

In The Last Decade

Chenghua Luo

55 papers receiving 740 citations

Peers

Chenghua Luo
Jamie Coupar United States
Tristan V. de Jong Netherlands
D.R. Jones United States
Miguel Fidalgo United States
Valentina Matti Italy
Miryana Dobreva Italy
Nicholas Shukeir Germany
Miguel Foronda Spain
Jeff S. Pawlikowski United States
Marcus Järås Sweden
Jamie Coupar United States
Chenghua Luo
Citations per year, relative to Chenghua Luo Chenghua Luo (= 1×) peers Jamie Coupar

Countries citing papers authored by Chenghua Luo

Since Specialization
Citations

This map shows the geographic impact of Chenghua Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghua Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghua Luo more than expected).

Fields of papers citing papers by Chenghua Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenghua Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghua Luo. The network helps show where Chenghua Luo may publish in the future.

Co-authorship network of co-authors of Chenghua Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Chenghua Luo. A scholar is included among the top collaborators of Chenghua Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenghua Luo. Chenghua Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Feifei, Chenghua Luo, Lei Zhang, et al.. (2025). Inhibition Mechanism of Cinnamomum burmannii Leaf Essential Oil Against Aspergillus flavus and Aflatoxins. Foods. 14(4). 682–682. 3 indexed citations
2.
3.
Yu, Kai, Hui Gao, Shibo Liu, et al.. (2024). Perception of recurrence risk in patients with IgG4-related disease: a descriptive phenomenological study. Rheumatology Advances in Practice. 9(1). rkae148–rkae148. 1 indexed citations
4.
Luo, Chenghua, et al.. (2024). Rhizosphere microbiome regulation: Unlocking the potential for plant growth. Current Research in Microbial Sciences. 8. 100322–100322. 29 indexed citations
5.
Zhang, Xulin, Zhiyi Li, Chenghua Luo, et al.. (2024). Hydrogen sulfide mitigates ox‑LDL‑induced NLRP3/caspase‑1/GSDMD dependent macrophage pyroptosis by S‑sulfhydrating caspase‑1. Molecular Medicine Reports. 30(2). 12 indexed citations
6.
7.
Luo, Chenghua, Weihua Liang, Haijun Zhang, et al.. (2023). M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma. Journal of Translational Medicine. 21(1). 26–26. 22 indexed citations
8.
Zhang, Tong, et al.. (2022). Epithelioid Inflammatory Myofibroblastic Sarcoma with Leukemoid Reaction. Journal of College of Physicians And Surgeons Pakistan. 32(9). 1212–1215. 3 indexed citations
9.
Li, Xiangji, et al.. (2022). Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis. Radiation Oncology. 17(1). 215–215. 2 indexed citations
10.
Luo, Chenghua, Jing Liu, Yan Cao, et al.. (2021). Insufficient S-Sulfhydration of Methylenetetrahydrofolate Reductase Contributes to the Progress of Hyperhomocysteinemia. Antioxidants and Redox Signaling. 36(1-3). 1–14. 19 indexed citations
11.
Luo, Chenghua, Yan Li, Yan Cao, et al.. (2021). Abnormal nitration and S-sulfhydration modification of Sp1-CSE-H2S pathway trap the progress of hyperhomocysteinemia into a vicious cycle. Free Radical Biology and Medicine. 164. 20–33. 16 indexed citations
12.
Li, Xiangji, Tong Wu, Mengmeng Xiao, et al.. (2021). Adjuvant therapy for retroperitoneal sarcoma: a meta-analysis. Radiation Oncology. 16(1). 196–196. 8 indexed citations
13.
Tseng, William W., Jun Chen, Dakshesh B. Patel, et al.. (2020). Multidisciplinary sarcoma tumor board: retroperitoneal liposarcoma. Chinese Clinical Oncology. 9(2). 20–20. 8 indexed citations
14.
Liang, Jianfeng, Xun Ye, Xiaolin Chen, et al.. (2020). Prognostic factors of patients with Gliomas – an analysis on 335 patients with Glioblastoma and other forms of Gliomas. BMC Cancer. 20(1). 35–35. 117 indexed citations
15.
Fu, Yali, et al.. (2019). Neutrophil to Lymphocyte Ratio in Retroperitoneal Liposarcoma and Other Prognostic Factors. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Zhou, Naikang, et al.. (2018). Tracking significant modules and key genes for esophageal squamous cell carcinoma based on differential modules. Journal of Cancer Research and Therapeutics. 14(12). 1135–1135. 2 indexed citations
17.
Zhou, Naikang, et al.. (2016). MiRNA-155 and miRNA-132 as potential diagnostic biomarkers for pulmonary tuberculosis: A preliminary study. Microbial Pathogenesis. 100. 78–83. 24 indexed citations
18.
Luo, Chenghua, et al.. (2009). The differences between American and Chinese patients with Crohn’s disease. Colorectal Disease. 13(2). 166–170. 15 indexed citations
19.
Zhao, Yali, et al.. (2006). [Expression and clinical significance of LRP16 gene in human breast cancer].. PubMed. 25(7). 866–70. 17 indexed citations
20.
Luo, Chenghua. (1998). Nuclear localization is required for function of the essential clock protein FRQ. The EMBO Journal. 17(5). 1228–1235. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamie Coupar Breakdown of academic impact, for papers by Tristan V. de Jong Breakdown of academic impact, for papers by D.R. Jones Breakdown of academic impact, for papers by Miguel Fidalgo Breakdown of academic impact, for papers by Valentina Matti Breakdown of academic impact, for papers by Miryana Dobreva Breakdown of academic impact, for papers by Nicholas Shukeir Breakdown of academic impact, for papers by Miguel Foronda Breakdown of academic impact, for papers by Jeff S. Pawlikowski Breakdown of academic impact, for papers by Marcus Järås
Rankless by CCL
2026